Adare acquires Orbis for drug discovery
May 4, 2020 -- Adare Pharmaceuticals on April 30 acquired pharmaceutical technology firm Orbis Biosciences. Financial details were not disclosed. The acquisition will enhance Adare's ability to manufacture products for the global pharmaceutical, animal health, and over-the-counter markets.
AbCellera secures COVID-19 drug development funding
May 4, 2020 -- AbCellera Biologics has secured $175.6 million Canadian ($124.7 million U.S.) from the Canadian government's Innovation, Science, and Economic Development Strategic Innovation Fund to advance its efforts to discover antibodies for use in antiviral COVID-19 drugs.
FDA issues EUA for remdesivir to treat severe COVID-19 cases
May 4, 2020 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the investigational antiviral drug remdesivir to be used for the treatment of COVID-19. The EUA was issued to Gilead Sciences on Friday, May 1.
U.K. schools get $3.8M to build COVID-19 vaccine, more
May 1, 2020 -- Citadel and Citadel Securities gifted 3 million pounds (about $3.8 million U.S.) to medical universities to accelerate COVID-19 research and vaccine development.
AMRI ups hydroxychloroquine sulfate API production
May 1, 2020 -- AMRI Global will boost production of hydroxychloroquine sulfate active pharmaceutical ingredients (API) due to its potential effectiveness in treating COVID-19 symptoms in patients.
Trio, Ajinomoto to develop cancer therapeutic
May 1, 2020 -- Cancer therapeutics company Trio Pharmaceuticals and biopharmaceutical contract development and manufacturing company Ajinomoto Bio-Pharma Services have announced a partnership to develop cancer therapeutics.
Inovio expands manufacturing for COVID-19 vaccine
May 1, 2020 -- Inovio has partnered with German contract manufacturer Richter-Helm BioLogics to produce large-scale quantities of Inovio's investigational DNA vaccine.
Kedrion, Kamada partner to combat COVID-19
April 29, 2020 -- Biopharmaceutical firms Kedrion Biopharma and Kamada are collaborating on the creation and clinical distribution of a plasma-derived anti-SARS-CoV-2 treatment product.
FDA, FTC issue warnings for fraudulent COVID-19 claims
April 29, 2020 -- Warning letters were issued on April 28 by the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) to two companies for selling fraudulent COVID-19 products.
Quotient, CytoAgents develop COVID-19 cytokine storm treatment
April 28, 2020 -- A new collaboration between Quotient Sciences and CytoAgents will accelerate the development of a lead COVID-19 drug candidate to human clinical trials, the companies announced.
Conferences
ESMO Virtual Congress 2020
September 14-29
Online
2020 ACCP Annual Meeting
September 20-22
Online
BioProcess International West
September 21-25
Online
BioProcess International
September 21-25
Online
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter